Log in

Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).
Date Range: 

 Innovate BiopharmaceuticalsKazia TherapeuticsProvectus BiopharmaceuticalsCitius PharmaceuticalsZomedica Pharmaceuticals Corp (NYSEAMERICAN)
SymbolNASDAQ:INNTNASDAQ:KZIAOTCMKTS:PVCTNASDAQ:CTXRNYSE:ZOM
Price Information
Current Price$0.49$2.65$0.05$0.74$0.16
52 Week RangeBuyN/AN/ABuyBuy
Analyst Ratings
Consensus RecommendationBuyN/AN/ABuyBuy
Consensus Price Target$10.00N/AN/A$5.50N/A
% Upside from Price Target1,940.82% upsideN/AN/A638.85% upsideN/A
Trade Information
Market Cap$19.42 million$18.76 million$17.66 million$23.30 million$17.82 million
Beta-1.122.070.681.380.19
Average Volume194,71824,205405,3971,154,6705,275,773
Sales & Book Value
Annual RevenueN/A$1.12 millionN/AN/AN/A
Price / SalesN/A17.08N/AN/AN/A
CashflowN/AN/AN/AN/AN/A
Price / CashN/AN/AN/AN/AN/A
Book Value($0.27) per share$1.63 per share($0.06) per share$0.84 per share($0.09) per share
Price / BookN/A1.63N/AN/AN/A
Profitability
Net Income$-27,050,000.00$-7,340,000.00$-6,920,000.00$-15,560,000.00$-19,780,000.00
EPS($0.98)($1.25)N/AN/A($0.19)
Trailing P/E RatioN/AN/AN/AN/AN/A
Forward P/E RatioN/AN/A
P/E GrowthN/AN/AN/AN/AN/A
Net MarginsN/AN/AN/AN/AN/A
Return on Equity (ROE)N/AN/AN/A-73.49%N/A
Return on Assets (ROA)-234.42%N/A-293.01%-61.72%-302.43%
Dividend
Annual PayoutN/AN/AN/AN/AN/A
Dividend YieldN/AN/AN/AN/AN/A
Three-Year Dividend GrowthN/AN/AN/AN/AN/A
Payout RatioN/AN/AN/AN/AN/A
Years of Consecutive Dividend GrowthN/AN/AN/AN/AN/A
Debt
Debt-to-Equity RatioN/AN/AN/AN/AN/A
Current Ratio0.35%2.44%0.33%0.78%0.87%
Quick Ratio0.35%N/A0.33%0.78%0.87%
Ownership Information
Institutional Ownership Percentage6.77%4.03%0.03%2.18%11.74%
Insider Ownership Percentage7.90%1.00%4.50%58.52%51.80%
Miscellaneous
Employees8N/A27N/A
Shares Outstanding41.33 million7.22 million390.69 million31.49 million108.04 million
Next Earnings Date5/8/2020 (Estimated)N/A5/11/2020 (Estimated)5/20/2020 (Estimated)5/8/2020 (Estimated)
OptionableOptionableNot OptionableNot OptionableNot OptionableNot Optionable

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel